Prolonged COVID-19 infection in a child with lymphoblastic non-Hodgkin lymphoma: which is the best management?

Autor: Gattuso, Giovanna, Schiavello, Elisabetta, Oltolini, Chiara, Biassoni, Veronica, Terenziani, Monica, Chiaravalli, Stefano, Podda, Marta Giorgia, Meazza, Cristina, Luksch, Roberto, Ferrari, Andrea, Casanova, Michela, Sironi, Giovanna, Bergamaschi, Luca, Puma, Nadia, Spreafico, Filippo, Massimino, Maura
Zdroj: Tumori Journal; December 2022, Vol. 108 Issue: 6 pNP1-NP4, 4p
Abstrakt: During the coronavirus disease 2019 (COVID-19) pandemic, oncologists have managed patients at higher risk of having a severe course of this infection. This raises new questions about their correct management, as well as the difficulty of distinguishing tumor/treatments complications from those related to COVID-19. We report a case of an 11-year-old boy undergoing treatment for T-cell lymphoblastic lymphoma who experienced a prolonged COVID-19 course. Oncologic therapy was continued without significant changes compared to the initially planned treatment. No relevant complications occurred. COVID-19 convalescent plasma was administered, resulting in a positive antibody titer after 24 days.
Databáze: Supplemental Index